Why Dollar-Cost Averaging Wins — The Math of Patience.
There is a strategy that requires no skill, no timing, no insider knowledge, and no prediction about which direction the market moves next. It has outperformed the majority of active fund managers over every meaningful time horizon. It is available to anyone with a brokerage account and a few dollars a month.
It is dollar-cost averaging. And the reason it works is not intuition. It is arithmetic.
Dollar-cost averaging means investing a fixed amount of money at regular intervals — weekly, biweekly, monthly — regardless of whether the market is up or down. You do not try to buy at the bottom. You do not wait for a dip. You buy on schedule, every time, the same amount.
When prices are high, your fixed amount buys fewer shares. When prices are low, the same amount buys more shares. Over time, this mechanical process lowers your average cost per share without requiring you to predict anything.
Here is a simplified example. Suppose you invest $500 per month into an S&P 500 index fund for twelve months. The price fluctuates between $400 and $500 per share across the year.
In the months when the price is $400, your $500 buys 1.25 shares. In the months when the price is $500, your $500 buys 1.0 share. At the end of the year, your average cost per share is lower than the simple average of the prices — because you automatically bought more when it was cheap and less when it was expensive. You did not need to know it was cheap at the time. The math did it for you.
Now add compound interest, and the effect accelerates.
The S&P 500 has delivered an average annual return of approximately 10.5% since 1957, according to Investopedia. That means $1,000 invested today, at 10.5% annually, becomes roughly $2,718 in ten years. Not because you did anything clever in year three or year seven. Because you stayed.
If you invest $500 per month at 10.5% average annual return for 20 years, your total contributions are $120,000. But the ending value is approximately $383,000. The difference — $263,000 — is pure compound growth. Money your money made while you were sleeping, working, or arguing on the internet about which stock will moon next quarter.
This is the snowball effect. The longer the hill, the larger the snowball. Time is not a variable in this equation. It is the engine.
Now, a note of intellectual honesty. Vanguard's research, examining market data from 1976 through 2022, found that lump-sum investing outperformed dollar-cost averaging between 61.6% and 73.7% of the time across various markets. This makes sense — markets go up more often than they go down, so putting money in earlier gives it more time to grow.
So why do we still recommend DCA?
Because the Vanguard study assumes you have a lump sum to invest. Most people do not. Most people earn a paycheck, pay rent, and invest what remains. For them, DCA is not a suboptimal strategy — it is the only realistic strategy. And even for those who do have a lump sum, DCA provides something the math does not capture: psychological survivability. If you invest $100,000 on Monday and the market drops 15% by Friday, the emotional damage may cause you to sell at the worst possible time. DCA avoids that trauma by spreading your exposure.
The real enemy of long-term returns is not buying at the wrong price. It is selling in a panic. DCA is insurance against your own worst instincts.
Now here is where leverage destroys everything DCA builds.
Dollar-cost averaging works because it assumes you can survive every drawdown. You buy more when prices fall. You never face a margin call. You never get liquidated. The strategy requires nothing except continued participation.
Leverage removes that guarantee.
A 3x leveraged ETF does not give you 3x the long-term return. It gives you 3x the daily return, and over time, volatility decay eats the position alive. We have documented this repeatedly. LABD — the 3x inverse biotech ETF — has undergone four reverse splits, most recently a 1-for-10 split in September 2025. MSTU and MSTX — 2x leveraged Strategy (formerly MicroStrategy) ETFs — lost over 80% while the underlying stock gained 6%. The 3x Long IonQ ETP on the London Stock Exchange was forcibly delisted.
The pattern is always the same. Leverage amplifies gains in theory and destroys capital in practice. A 33% drop on a 3x product is a 99% loss. And unlike an index fund, a leveraged product cannot recover from that math — because the base from which it compounds has been destroyed.
Taking out a loan to invest follows the same logic. You are adding leverage to a position that requires time and patience. The moment the market drops and your loan payment is due, you are forced to sell at exactly the worst time. You have converted a temporary paper loss into a permanent real loss — and you still owe the bank.
This is why our message has never changed. Do not use leverage. Do not take loans to invest. If individual stocks feel too risky, buy SPY or QQQ through dollar-cost averaging. If even that feels like too much, cash in a money-market fund earning 3.5% is not doing nothing — it is preserving your ability to invest later.
The math of patience is simple. Invest regularly. Do not borrow. Do not leverage. Let compound interest and time do what they have done for a century.
The market does not reward the smartest investor. It rewards the one who is still there.
Related Posts:
